The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin

Free Radical Biology and Medicine

Volumn 44, Issue 7, 2008, Pages 1420-1432

  He, Xiaojun ^a   Azarov, Ivan ^a   Jeffers, Anne ^a   Presley, Tennille ^a   Richardson, Jodi ^a   King, S Bruce ^a   Gladwin, Mark T ^b,c   Kim Shapiro, Daniel B ^b  

^a WAKE FOREST UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Angeli's salt; Free radicals; Hemoglobin; Hemolysis; Nitric oxide; Nitroxyl; Red blood cell

Indexed keywords

ANGELI SALT; HEMOGLOBIN; IRON; METHEMOGLOBIN; NITRIC OXIDE; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL ENCAPSULATION; CELL FREE SYSTEM; ERYTHROCYTE; INTRAVASCULAR HEMOLYSIS; LUNG VASOCONSTRICTION; NITROSYLATION; OXIDATION REDUCTION REACTION; OXYGENATION; PLASMA; PRIORITY JOURNAL; REACTION ANALYSIS; VASOCONSTRICTION;

FREE RADICAL SCAVENGERS; FREE RADICALS; HEMATOCRIT; HEMOGLOBINS; HEMOLYSIS; HUMANS; KINETICS; MODELS, CHEMICAL; NITRIC OXIDE; NITROGEN OXIDES; OXIDATION-REDUCTION; SALTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 41049115924     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.12.038     Document Type: Article

References (107)

1. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
2. Ignarro L.J., Byrns R.E., Buga G.M., and Wood K.S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties identical to those of nitric oxide radical. Circ. Res. 61 (1987) 866-879
3. Katsuki S., Arnold W., Mittal C., and Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3 (1977) 23-35
4. Palmer R.M.J., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
5. Ignarro L.J. Nitric oxide biology and pathobiology (2000), Academic Press, San Diego
6. Yuan S.Y. New insights into eNOS signaling in microvascular permeability. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1029-H1031
7. Bucci M., Roviezzo F., Posadas I., Yu J., Parente L., Sessa W.C., Ignarro L.J., and Cirino G. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 904-908
8. Predescu D., Predescu S., Shimizu J., Miyawaki-Shimizu K., and Malik A.B. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am. J. Physiol. 289 (2005) L371-L381
9. Murohara T., Asahara T., Silver M., Bauters C., Masuda H., Kalka C., Kearney M., Chen D., Symes J.F., Fishman M.C., Huang P.L., and Isner J.M. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101 (1998) 2567-2578
10. Cooke J.P. NO and angiogenesis. Atherosclerosis 4 (2003) 53-60
11. Battinelli E.M., and Loscalzo J. Nitric oxide and platelet-mediated hemostasis. In: Loscalzo J., and Vita J.A. (Eds). Nitric oxide and the cardiovascular system (2000), Humana Press, Totowa, NJ 123-138
12. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res. 88 (2001) 756-762
13. Nakashima S., Tohmatsu T., Hattori H., Okano Y., and Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human platelets. Biochem. Biophys. Res. Commun. 135 (1986) 1099-1104
14. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4651-4655
15. Tailor A., and Granger D.N. Role of adhesion molecules in vascular regulation and damage. Curr. Hypertens. Rep. 2 (2000) 78-83
16. Hickey M.J., and Kubes P. Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Exp. Physiol. 82 (1997) 339-348
17. Rother R.P., Bell L., Hillmen P., and Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin-a novel mechanism of human disease. JAMA 293 (2005) 1653-1662
18. Minneci P.C., Deans K.J., Zhi H., Yuen P.S.T., Star R.A., Banks S.M., Schechter A.N., Natanson C., Gladwin M.T., and Solomon S.B. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J. Clin. Invest. 115 (2005) 3409-3417
19. Reiter C.D., Wang X.D., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8 (2002) 1383-1389
20. Coggins M.P., and Bloch K.D. Nitric oxide in the pulmonary vasculature. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1877-1885
21. Marin E., and Sessa W.C. Role of endothelial-derived nitric oxide in hypertension and renal disease. Curr. Opin. Nephrol. Hypertens. 16 (2007) 105-110
22. Kato G.J., Gladwin M.T., and Steinberg M.H. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 21 (2007) 37-47
23. Ignarro L.J., Balestrieri M.L., and Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 73 (2007) 326-340
24. Sobolewski P., Gramaglia I., Frangos J., Intaglietta M., and van der Heyde H.C. Nitric oxide bioavailability in malaria. Trends Parasitol. 21 (2005) 415-422
25. Eich R.F., Li T.S., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Mathews A.J., Johnson K.A., Smith R.D., Phillips G.N., and Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry-US 35 (1996) 6976-6983
26. Doyle M.P., and Hoekstra J.W. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J. Inorg. Biochem. 14 (1981) 351-358
27. ×-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry-US 40 (2001) 3385-3395
28. Huang K.T., Huang Z., and Kim-Shapiro D.B. Nitric oxide red blood cell membrane permeability at high and low oxygen tension. Nitric Oxide 16 (2007) 209-216
29. Cassoly R., and Gibson Q.H. Conformation, co-operativity and ligand binding in human hemoglobin. J. Mol. Biol. 91 (1975) 301-313
30. Huang K.T., Huang Z., and Kim-Shapiro D.B. Nitric oxide red blood cell membrane permeability at high and low oxygen tension. Nitric Oxide 16 (2006) 209-216
31. Sharma V.S., and Ranney H.M. Dissociation of NO from nitrosylhemoglobin. J. Biol. Chem. 253 (1978) 6467-6472
32. Azizi F., Kielbasa J.E., Adeyiga A.M., Maree R.D., Frazier M., Yakubu M., Shields H., King S.B., and Kim-Shapiro D.B. Rates of nitric oxide dissociation from hemoglobin. Free Radic. Biol. Med. 39 (2005) 145-151
33. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 9265-9269
34. Lancaster J.R. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8137-8141
35. Carlsen E., and Comroe J.H. The rate of uptake of carbon monoxide and of nitric oxide by normal and human erythrocytes and experimentally produced spherocytes. J. Gen. Physiol. 42 (1958) 83-107
36. Coin J.T., and Olson J.S. Rate of oxygen uptake by human red blood -cells. J. Biol. Chem. 254 (1979) 1178-1190
37. Butler A.R., Megson I.L., and Wright P.G. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim. Biophys. Acta 1425 (1998) 168-176
38. Vaughn M.W., Kuo L., and Liao J.C. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J. Physiol. Heart Circ. Physiol. 43 (1998) H2163-H2176
39. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., and Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8757-8761
40. Vaughn M.W., Huang K.T., Kuo L., and Liao J.C. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J. Biol. Chem. 275 (2000) 2342-2348
41. Vaughn M.W., Huang K.T., Kuo L., and Liao J.C. Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide 5 (2001) 18-31
42. Liu X.P., Samouilov A., Lancaster J.R., and Zweier J.L. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J. Biol. Chem. 277 (2002) 26194-26199
43. Huang K.T., Han T.H., Hyduke D.R., Vaughn M.W., Van Herle H., Hein T.W., Zhang C.H., Kuo L., and Liao J.C. Modulation of nitric oxide bioavailability by erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11771-11776
44. Liu X.P., Miller M.J.S., Joshi M.S., Sadowska-Krowicka H., Clark D.A., and Lancaster J.R. Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273 (1998) 18709-18713
45. Azarov I., Huang K.T., Basu S., Gladwin M.T., Hogg N., and Kim-Shapiro D.B. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J. Biol. Chem. 280 (2005) 39024-39032
46. Kim-Shapiro D.B., Schechter A.N., and Gladwin M.T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 697-705
47. Han T.H., and Liao J.C. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim. Biophys. Acta 1723 (2005) 135-142
48. Loscalzo J. Nitric oxide binding and the adverse effects of cell-free hemoglobins: what makes us different from earthworms. J. Lab. Clin. Med. 129 (1997) 580-583
49. 2 carriers determine constriction of resistance arteries and hypertension. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H908-H915
50. Matheson B., Kwansa H.E., Bucci E., Rebel A., and Koehler R.C. Vascular response to infusions of a nonextravasating hemoglobin polymer. J. Appl. Physiol. 93 (2002) 1479-1486
51. Dull R.O., DeWitt B.J., Dinavahi R., Schwartz L., Hubert C., Pace N., and Fronticelli C. Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J. Appl. Physiol. 97 (2004) 1930-1937
52. 2 biotransport: a computer model. Microcirculation 11 (2004) 337-349
53. Vogel W.M., Dennis R.C., Cassidy G., Apstein C.S., and Valeri C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251 (1986) H413-H420
54. Hess J.R., Macdonald V.W., and Brinkley W.W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74 (1993) 1769-1778
55. Lee R., Neya K., Svizzero T.A., and Vlahakes G.J. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J. Appl. Physiol. 79 (1995) 236-242
56. Murray J.A., Ledlow A., Launspach J., Evans D., Loveday M., and Conklin J.L. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109 (1995) 1241-1248
57. Ulatowski J.A., Nishikawa T., Matheson-Urbaitis B., Bucci E., Traystman R.J., and Koehler R.C. Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit. Care Med. 24 (1996) 558-565
58. Sloan E.P., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M.N., and Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock-a randomized controlled efficacy trial. JAMA 282 (1999) 1857-1864
59. Dou Y., Maillett D.H., Eich R.F., and Olson J.S. Myoglobin as a model system for designing heme protein based blood substitutes. Biophys. Chemist 98 (2002) 127-148
60. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., and Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 16 (1998) 672-676
61. Olson J.S., Foley E.W., Rogge C., Tsai A.L., Doyle M.P., and Lemon D.D. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic. Biol. Med. 36 (2004) 685-697
62. Patel R.P. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic. Biol. Med. 28 (2000) 1518-1525
63. Gulati A., Barve A., and Sen A.P. Pharmacology of hemoglobin therapeutics. J. Lab. Clin. Med. 133 (1999) 112-119
64. Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser K.R., Fratantoni J.C., and Alayash A.I. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. 129 (1997) 603-610
65. Sharma A.C., Singh G., and Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am. J. Physiol. Heart Circ. Physiol. 38 (1995) H1379-H1388
66. Thompson A., McGarry A.E., Valeri C.R., and Lieberthal W. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat-role of nitric oxide. J. Appl. Physiol. 77 (1994) 2348-2354
67. Sampei K., Ulatowski J.A., Asano Y., Kwansa H., Bucci E., and Koehler R.C. Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H1191-H1201
68. Reiter C.D., and Gladwin M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 10 (2003) 99-107
69. Gladwin M.T. Unraveling the hemolytic subphenotype of sickle cell disease. Blood 106 (2005) 2925-2926
70. Nolan V.G., Wyszynski D.F., Farrer L.A., and Steinberg M.H. Hemolysis-associated priapism in sickle cell disease. Blood 106 (2005) 3264-3267
71. Morris C.R., Vichinsky E.P., Kato G.J., Gladwin M.T., Hazen S., and Morris S.M. Arginine metabolism, pulmonary hypertension, and sickle cell disease-in reply. JAMA 294 (2005) 2433-2434
72. Gladwin M.T., Sachdev V., Jison M.L., Shizukuda Y., Plehn J.F., Minter K., Brown B., Coles W.A., Nichols J.S., Ernst I., Hunter L.A., Blackwelder W.C., Schechter A.N., Rodgers G.P., Castro O., and Ognibene F.P. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350 (2004) 886-895
73. Kato G.J., McGowan V.R., Machado R.F., Little J.A., Taylor J., Morris C.R., Nichols J.S., Wang X., Poljakovic M., Morris J., Sidney M., and Gladwin M.T. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 107 (2006) 2279-2285
74. Wang X.D., Tanus-Santos J.E., Reiter C.D., Dejam A., Shiva S., Smith R.D., Hogg N., and Gladwin M.T. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11477-11482
75. Ballas S.K., and Marcolina M.J. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 46 (2006) 105-110
76. Naumann H., Diggs L., Barreras L., and Williams B. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am. J. Clin. Pathol. 56 (1971) 137-147
77. Jeffers A., Gladwin M.T., and Kim-Shapiro D.B. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic. Biol. Med. 41 (2006) 1557-1565
78. Tanaka K., Kanamori Y., Sato T., Kondo C., Katayama Y., Yada I., Yuasa H., and Kusagawa M. Administration of haptoglobin during cardiopulmonary bypass surgery. Trans. Am. Soc. Artif. Intern. Organs 37 (1991) M482-M483
79. Cooper C.E. Nitric oxide and iron proteins. Biochim. Biophys. Acta Bioenerg. 1411 (1999) 290-309
80. Head C.A., Brugnara C., Martinez-Ruiz R., Kacmarek R.M., Bridges K.R., Kuter D., Bloch K.D., and Zapol W.M. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J. Clin. Invest. 100 (1997) 1193-1198
81. Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat. Rev. Drug Discov. 3 (2004) 152-159
82. Motterlini R., Foresti R., Vandegriff K., Intaglietta M., and Winslow R.M. Oxidative stress response in vascular endothelial cells exposed to acellular hemoglobin -solutions. Am. J. Physiol. Heart Circ. Physiol. 38 (1995) H648-H655
83. Balla J., Jacob H.S., Balla G., Nath K., Eaton J.W., and Vercellotti G.M. Endothelial cell heme uptake from heme proteins-induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9285-9289
84. Doyle M.P., Mahapatro S.N., Broene R.D., and Guy J.K. Oxidation and reduction of hemoproteins by trioxodinitrate(II)-the role of nitrosyl hydride and nitrite. J. Am. Chem. Soc. 110 (1988) 593-599
85. Miranda K.M., Paolocci N., Katori T., Thomas D.D., Ford E., Bartberger M.D., Espey M.G., Kass D.A., Feelisch M., Fukuto J.M., and Wink D.A. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9196-9201
86. Miranda K.M., Nims R.W., Thomasa D.D., Espey M.G., Citrin D., Bartberger M.D., Paolocci N., Fukuto J.M., Feelisch M., and Wink D.A. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins-a chemical discussion of the differential biological effects of these redox related products of NOS. J. Inorg. Biochem. 93 (2003) 52-60
87. Huang Z., Louderback J.G., Goyal M., Azizi F., King S.B., and Kim-Shapiro D.B. Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim. Biophys. Acta 1568 (2001) 252-260
88. Geraci G., Parkhurst L.J., and Gibson Q.H. Preparation and properties of a- and b-chains from human hemoglobin. J. Biol. Chem. 17 (1969) 4664-4667
89. Liochev S.I., and Fridovich I. Copper,zinc superoxide dismutase as a univalent NO oxidoreductase and as a dichlorofluorescin peroxidase. J. Biol. Chem. 276 (2001) 35253-35257
90. Doyle M.P., Pickering R.A., Dykstra R.L., Nelson C.L., and Boyer R.F. Involvement of peroxide and superoxide in the oxidation of hemoglobin by nitrite. Biochem. Biophys. Res. Commun. 105 (1982) 127-132
91. Arnold E.V., and Bohle D.S. Isolation and oxygenation reactions of nitrosylmyoglobins. Methods Enzymol. 269 (1996) 41-55
92. Nakamura K., Watanabe M., Sawai-Tanimoto S., and Ikeda T. A low catalase activity in dog erythrocytes is due to a very low content of catalase protein despite having a normal specific activity. Int. J. Biochem. Cell Biol. 30 (1998) 823-831
93. Goth L. Human erythrocyte catalase, isolation with an improved method, characterization and comparison to bovine liver catalase. Enzyme 41 (1989) 191-199
94. Miyataasano M., Ito K., Ikeda H., Sekiguchi S., Arai K., and Taniguchi N. Purification of copper-zinc superoxide dismutase and catalase from human erythrocytes by copper chelate affinity chromatography. J. Chromatogr. 370 (1986) 501-507
95. Nicholls P., Fita I., and Loewen P.C. Enzymology and structure of catalases. Adv. Inorg. Chem. 51 (2001) 51-106
96. D'Agnillo F., and Alayash A.I. Interactions of hemoglobin with hydrogen peroxide alters thiol levels and course of endothelial cell death. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H1880-H1889
97. Huang J.M., Kim-Shapiro D.B., and King S.B. Catalase-mediated nitric oxide formation from hydroxyurea. J. Med. Chem. 47 (2004) 3495-3501
98. Rodkey F.L. Mechanism for conversion of oxyhemoglobin to methemoglobin by nitrite. Clin. Chem. 22 (1976) 1986-1990
99. Huang Z., Shiva S., Kim-Shapiro D.B., Patel R.P., Ringwood L.A., Irby C.E., Huang K.T., Ho C., Hogg N., Schechter A.N., and Gladwin M.T. Enzymatic function of hemoglobin as a nitrite reductase that produces nitric oxide under allosteric control. J. Clin. Invest. 115 (2005) 2099-2107
100. Huang K.T., Keszler A., Patel N., Patel R.P., Gladwin M.T., Kim-Shapiro D.B., and Hogg N. The reaction between nitrite and deoxyhemoglobin: reassessment of reaction kinetics and stoichiometry. J. Biol. Chem. 280 (2005) 31126-31131
101. Fernandez B.O., and Ford P.C. Nitrite catalyzes ferriheme protein reductive nitrosylation. J. Am. Chem. Soc. 125 (2003) 10510-10511
102. Basu S., Grubina R., Huang J., Conradie J., Huang Z., Jeffers A., Jiang A., He X., Azarov I., Seibert R., Mehta A., Patel R., King S.B., Hogg N., Ghosh A., Gladwin M.T., and Kim-Shapiro D.B. Catalytic generation of N2O3 by a concerted nitrite reductase and anhydrase activity of hemoglobin. Nat. Chem. Biol. 3 (2007) 785-794
103. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X.L., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon R.O., and Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9 (2003) 1498-1505
104. Dejam A., Hunter C.J., Pelletier M.M., Hsu L.L., Machado R.F., Shiva S., Power G.G., Kelm M., Gladwin M.T., and Schechter A.N. Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood 106 (2005) 734-739
105. Tsoukias N.M., and Popel A.S. Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H2265-H2277
106. Olson J.S. Stopped-flow, rapid mixing measurements of ligand binding to hemoglobin and red cells. Methods Enzymol. 76 (1981) 631-651
107. Kim-Shapiro D.B. Hemoglobin-nitric oxide cooperativity: is NO the third respiratory ligand?. Free Radic. Biol. Med. 36 (2004) 402-412